MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients

Clinical trial NCT04032626 · COMPLETED

Trial details

NCT number: NCT04032626
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cognitive Impairment, Mild Cognitive Dysfunction Amyloid Plaque Neurodegeneration Inflammation, Brain

Start date: 2020-07-22
Primary completion: 2025-05-31
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.